162 related articles for article (PubMed ID: 16762583)
21. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
22. Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings.
Obirikorang C; Quaye L; Acheampong I
BMC Infect Dis; 2012 Jun; 12():128. PubMed ID: 22676809
[TBL] [Abstract][Full Text] [Related]
23. Total lymphocyte count as a surrogate marker to predict CD4 count in human immunodeficiency virus-infected children: a retrospective evaluation.
Wang Y; Li Y; Wang C; Liang S; Guo J; Li Z; Zhang M; Li W
Pediatr Infect Dis J; 2012 Jan; 31(1):61-3. PubMed ID: 22217967
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a manual CD4+ count kit for determination of absolute CD4+ T-lymphocyte counts.
Mitchai M; Susaengrat W; Krissadarak K; Mitchai J; Leeratanapetch N
J Med Assoc Thai; 2008 Oct; 91(10):1495-8. PubMed ID: 18972890
[TBL] [Abstract][Full Text] [Related]
25. The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients.
Olawumi HO; Olatunji PO
HIV Med; 2006 Sep; 7(6):351-5. PubMed ID: 16903978
[TBL] [Abstract][Full Text] [Related]
26. Total lymphocyte counts in adult HIV/AIDS patients in Port Moresby General Hospital.
Lavu EK; Kutson N; Connie C; Tau G; Sims P
P N G Med J; 2004; 47(1-2):31-8. PubMed ID: 16496513
[TBL] [Abstract][Full Text] [Related]
27. The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.
Bishai D; Colchero A; Durack DT
AIDS; 2007 Jun; 21(10):1333-40. PubMed ID: 17545710
[TBL] [Abstract][Full Text] [Related]
28. Correlation among total lymphocyte count, absolute CD4+ count, and CD4+ percentage in a group of HIV-1-infected South African patients.
van der Ryst E; Kotze M; Joubert G; Steyn M; Pieters H; van der Westhuizen M; van Staden M; Venter C
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):238-44. PubMed ID: 9803965
[TBL] [Abstract][Full Text] [Related]
29. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
[TBL] [Abstract][Full Text] [Related]
30. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
[TBL] [Abstract][Full Text] [Related]
31. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S
Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a single-platform microcapillary flow cytometer for enumeration of absolute CD4+ T-lymphocyte counts in HIV-1 infected Thai patients.
Pattanapanyasat K; Phuang-Ngern Y; Lerdwana S; Wasinrapee P; Sakulploy N; Noulsri E; Thepthai C; McNicholl JM
Cytometry B Clin Cytom; 2007 Sep; 72(5):387-96. PubMed ID: 17474130
[TBL] [Abstract][Full Text] [Related]
33. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
34. The use of total lymphocyte count (TLC) as an independent criterion for initiating HAART in resource-poor countries.
Lee SS; Wong KH
J Infect; 2005 Jan; 50(1):66-7. PubMed ID: 15603843
[TBL] [Abstract][Full Text] [Related]
35. [Ocular complications of HIV/AIDS in Cameroon: is there is any correlation with the level of CD4 lymphocytes count?].
Ebana Mvogo C; Ellong A; Bella AL; Luma H; Achu Joko H
Bull Soc Belge Ophtalmol; 2007; (305):7-12. PubMed ID: 18018421
[TBL] [Abstract][Full Text] [Related]
36. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy.
D'Orsogna LJ; Krueger RG; McKinnon EJ; French MA
AIDS; 2007 Aug; 21(13):1747-52. PubMed ID: 17690573
[TBL] [Abstract][Full Text] [Related]
37. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort.
Glencross DK; Janossy G; Coetzee LM; Lawrie D; Scott LE; Sanne I; McIntyre JA; Stevens W
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S131-40. PubMed ID: 18228566
[TBL] [Abstract][Full Text] [Related]
38. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
39. Serum concentration of acute phase protein and lipid profile in HIV-1 seropositive patients and its relationship to the progression of the disease.
Ogunro PS; Idogun ES; Ogungbamigbe TO; Ajala MO; Olowu OA
Niger Postgrad Med J; 2008 Dec; 15(4):219-24. PubMed ID: 19169337
[TBL] [Abstract][Full Text] [Related]
40. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women.
Floris-Moore M; Howard AA; Lo Y; Arnsten JH; Santoro N; Schoenbaum EE
HIV Med; 2006 Oct; 7(7):421-30. PubMed ID: 16925727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
